VivoSim Labs, Inc.
VIVSNASDAQHealthcareBiotechnology
As of Oct 15, 2026 close
- Market cap
- $546.22K
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $0.16$3.40
- Volume (live)
- -
- Avg. volume (3M)
- 925.49K
VivoSim Labs (VIVS) Stock Price & Financial Analysis
VivoSim Labs Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $0.15 - $0.19 |
|---|---|
| 52-Week High | $3.40 |
| 52-Week Low | $0.16 |
| Open | $0.16 |
| Volume (last close) | 3.52M |
| Average Volume (3M) | 925.49K |
| Revenue (TTM) | 112.00K |
|---|---|
| Net Income (TTM) | -12.34M |
| Free Cash Flow (TTM) | -10.12M |
| EPS (TTM) | −$4.49 |
| Profit Margin | -11016.07% |
| Operating Margin | -10116.96% |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Market Cap | 546.22K |
|---|---|
| Shares Outstanding | 3.19M |
| Price to Sales (P/S) | 4.88 |
| Price to Book (P/B) | -0.23 |
| EV/EBITDA | 0.07 |
| 50-Day MA | $0.27 |
|---|---|
| 200-Day MA | $1.18 |
| 1-Year Change | −93.45% |
Source: Market prices and company fundamentals. Data as of Oct 15, 2026. Data sources and methodology
VivoSim Labs at a Glance
As of the Oct 15, 2026 close, VivoSim Labs (VIVS) has a market capitalization of $546.22K. The stock trades at 4.9× sales. Over the trailing twelve months it lost $12.34M on revenue of $112.00K and burned $10.12M of free cash flow. Revenue fell 21.1% year over year.
As of its latest reported balance sheet, it holds $1.67M in cash and securities against $316.00K of debt, a net cash position of $1.35M.
VivoSim Labs does not currently pay a dividend.
The share price is down 93.4% over the past year. At $0.17 (the Oct 15, 2026 close) it sits near the bottom of its 52-week range of $0.16 to $3.40, below its 200-day moving average of $1.18.
Frequently Asked Questions About VivoSim Labs
What is the current stock price for VIVS?
As of the Oct 15, 2026 close, VIVS stock trades at $0.17. The 52-week range is $0.16–$3.40, with a day range of $0.15–$0.19.
What is the P/E ratio for VIVS?
The P/E ratio (Price-to-Earnings) for VIVS is shown in the Key Statistics section. This valuation metric helps compare VivoSim Labs, Inc. to industry peers.
Does VIVS pay dividends?
VivoSim Labs does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for VIVS?
Analyst ratings and recommendations for VIVS are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.
What is the market cap of VIVS?
As of the Oct 15, 2026 close, VivoSim Labs's market capitalization is $546,224.445, classifying it as a micro-cap company. VivoSim Labs operates in the Healthcare sector within the Biotechnology industry.